{
    "code": "10000743",
    "url": "http:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=10000743",
    "time": "2017-03-31 03:06:11",
    "許可證字號": "衛署菌疫輸字第000743號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "有效日期": "107\/04\/25",
    "發證日期": "91\/11\/15",
    "許可證種類": "菌　疫",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA01000074306",
    "中文品名": "栓體舒注射液50毫克",
    "英文品名": "ACTILYSE INJECTION 50MG",
    "適應症": "急性冠狀動脈栓塞之血栓溶解、急性大片肺栓塞、急性缺血性中風之血栓溶解。",
    "劑型": "270注射劑",
    "包裝": "1小瓶盒裝 附1小瓶裝溶劑",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "05限由醫師使用",
    "主成分略述": [
        "RECOMBINANTHUMANTISSUE-TYPEPLASMINOGENACTIVATOR"
    ],
    "限制項目": "02輸　入",
    "申請商名稱": "1405201100  台灣百靈佳殷格翰股份有限公司",
    "主製造廠": {
        "主製造廠": "",
        "製造廠名稱": "F470215200  BOEHRINGER INGELHEIM PHARMA GMBH &amp; CO. KG",
        "製造廠廠址": "BIRKENDORFER STRASSE 65, 88397 BIBERACH AN DER RISS, GERMANY",
        "製造廠公司地址": "",
        "": ""
    },
    "CCC號列": "30021090001 其他血液分離部分及改質免疫產品，不論是否以生物技術方法取得Other blood fractions and modified immunological products, whether or not obtained by means of biotechnological process",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "2040000610",
            "成分名稱": "RECOMBINANT HUMAN TISSUE-TYPE PLASMINOGEN ACTIVATOR",
            "含量描述": "",
            "含量": "50.0000000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "020007430001-105-09-07.pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=10000743&Seq=042&Type=9"
        },
        {
            "title": "50 mg_外盒-104-12-25(廠商自行上傳).pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=10000743&Seq=002&Type=8"
        }
    ]
}